Tavera-Tapia, A., de la Hoya, M., Calvete, O., Martin-Gimeno, P., Fernández, V., Macías, J. A., Alonso, B., Pombo, L., de Diego, C., Alonso, R., Pita, G., Barroso, A., Urioste, M., Caldés, T., Newman, J. A., Benítez, J., & Osorio, A. (2019). RECQL5: Another DNA helicase potentially involved in hereditary breast cancer susceptibility.  Human mutation, 40(5), 566–577.

Larsson, K., Steinmetz, J., Bergqvist, F., Arefin, S., Spahiu, L., Wannberg, J., … Jakobsson, P. J. (2019). Biological characterization of new inhibitors of microsomal PGE synthase‐1 in preclinical models of inflammation and vascular tone. British Journal of Pharmacology, 176(24), 4625–4638.

Idborg, H., Zandian, A., Ossipova, E., Wigren, E., Preger, C., Mobarrez, F., ... Jakobsson, P. J. (2019). Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients. Frontiers in immunology, 10, 1029.

Bergqvist, F., Ossipova, E., Idborg, H., Raouf, J., Checa, A., Englund, K., ... Jakobsson, P. J. (2019). Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells. Frontiers in pharmacology, 10, 636.

Kirkby, N., Raouf, J., Ahmetaj-Shala, B., Liu, B., Mazi, S., Edin, M., ... Mitchell, J. (2019). Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis. Cardiovascular Research.

Bergqvist, F., Morgenstern, R., & Jakobsson, P. J. (2020). A review on mPGES-1 inhibitors: From preclinical studies to clinical applications. Prostaglandins & Other Lipid Mediators, 147, 106383.

Amon, S., Meier-Abt, F., Gillet, L. C., Dimitrieva, S., Theocharides, A., Manz, M. G., & Aebersold, R. (2019). Sensitive Quantitative Proteomics of Human Hematopoietic Stem and Progenitor Cells by Data-independent Acquisition Mass Spectrometry. Molecular & cellular proteomics : MCP, 18(7), 1454–1467.

Huang, Y., Mouttet, B., Warnatz, H., Risch, T., Rietmann, F., Frommelt, F., ... Bourquin, J. (2019). The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability. Cancer Cell, 36(6), 630-644.e9.

Schäfer, A., Gjerga, E., Welford, R. W., Renz, I., Lehembre, F., Groenen, P. M., … Gstaiger, M. (2019). Elucidating essential kinases of endothelin signalling by logic modelling of phosphoproteomics data. Molecular systems biology, 15(8), e8828.

Celis-Gutierrez, J., Blattmann, P., Zhai, Y., Jarmuzynski, N., Ruminski, K., Grégoire, C., … Malissen, B. (2019). Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell reports, 27(11), 3315–3330.e7.